Circulating brain-derived neurotrophic factor level in patients with primary open angle glaucoma

Background: Glaucoma constitutes a serious health problem in Nigeria and beyond. It is a leading cause of bilateral blindness and its burden remains high. There is a paucity of literature on the levels of circulating brain-derived neurotrophic factor (BDNF) in health and disease among Africans. In a...

Full description

Bibliographic Details
Main Authors: Ahmed Saidu, Sadiq Hassan, Ahmadu Shehu Mohammed, Isyaku Umar Yarube
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Sahel Medical Journal
Subjects:
Online Access:http://www.smjonline.org/article.asp?issn=1118-8561;year=2019;volume=22;issue=4;spage=164;epage=170;aulast=Saidu
id doaj-c143111e3004408f819f1c66f01e42bc
record_format Article
spelling doaj-c143111e3004408f819f1c66f01e42bc2020-11-25T02:15:26ZengWolters Kluwer Medknow PublicationsSahel Medical Journal2321-66892019-01-0122416417010.4103/smj.smj_63_18Circulating brain-derived neurotrophic factor level in patients with primary open angle glaucomaAhmed SaiduSadiq HassanAhmadu Shehu MohammedIsyaku Umar YarubeBackground: Glaucoma constitutes a serious health problem in Nigeria and beyond. It is a leading cause of bilateral blindness and its burden remains high. There is a paucity of literature on the levels of circulating brain-derived neurotrophic factor (BDNF) in health and disease among Africans. In addition, the dynamics and reasons for variation in the levels of BDNF in the local population of glaucoma patients are yet to be demonstrated. Objective: This study determined the circulating level of BDNF and factors associated with it among glaucoma patients. Materials and Methods: Serum concentration of BDNF and other oculo-visual and sociodemographic characteristics were determined in glaucoma patients and controls. Data were processed using IBM SPSS Statistics version 20. Results: Forty-four adult glaucoma patients of both sexes and 41 nonglaucoma controls matched for age and sex with an average age of about 50 years were studied. BDNF level among the glaucoma patients was higher (2.578 ± 1.394) than that of the controls (1.745 ± 0.707) (t = 3.436, P = 0.001). Glaucoma patients who were blind had the lowest levels of circulating BDNF (P = 0.022); the level of BDNF in the naïve patients (not yet placed on medication) is about five times less than in those patients placed on medication (P = 0.001). Circulating BDNF was associated with glaucoma treatment among the patients. Conclusion: The level of circulating BDNF in primary open angle glaucoma patients on treatment is high than those who were not on treatment. It influenced by coexisting medical conditions.http://www.smjonline.org/article.asp?issn=1118-8561;year=2019;volume=22;issue=4;spage=164;epage=170;aulast=Saidubrain-derived neurotrophic factorglaucomaoculo-visual symptoms
collection DOAJ
language English
format Article
sources DOAJ
author Ahmed Saidu
Sadiq Hassan
Ahmadu Shehu Mohammed
Isyaku Umar Yarube
spellingShingle Ahmed Saidu
Sadiq Hassan
Ahmadu Shehu Mohammed
Isyaku Umar Yarube
Circulating brain-derived neurotrophic factor level in patients with primary open angle glaucoma
Sahel Medical Journal
brain-derived neurotrophic factor
glaucoma
oculo-visual symptoms
author_facet Ahmed Saidu
Sadiq Hassan
Ahmadu Shehu Mohammed
Isyaku Umar Yarube
author_sort Ahmed Saidu
title Circulating brain-derived neurotrophic factor level in patients with primary open angle glaucoma
title_short Circulating brain-derived neurotrophic factor level in patients with primary open angle glaucoma
title_full Circulating brain-derived neurotrophic factor level in patients with primary open angle glaucoma
title_fullStr Circulating brain-derived neurotrophic factor level in patients with primary open angle glaucoma
title_full_unstemmed Circulating brain-derived neurotrophic factor level in patients with primary open angle glaucoma
title_sort circulating brain-derived neurotrophic factor level in patients with primary open angle glaucoma
publisher Wolters Kluwer Medknow Publications
series Sahel Medical Journal
issn 2321-6689
publishDate 2019-01-01
description Background: Glaucoma constitutes a serious health problem in Nigeria and beyond. It is a leading cause of bilateral blindness and its burden remains high. There is a paucity of literature on the levels of circulating brain-derived neurotrophic factor (BDNF) in health and disease among Africans. In addition, the dynamics and reasons for variation in the levels of BDNF in the local population of glaucoma patients are yet to be demonstrated. Objective: This study determined the circulating level of BDNF and factors associated with it among glaucoma patients. Materials and Methods: Serum concentration of BDNF and other oculo-visual and sociodemographic characteristics were determined in glaucoma patients and controls. Data were processed using IBM SPSS Statistics version 20. Results: Forty-four adult glaucoma patients of both sexes and 41 nonglaucoma controls matched for age and sex with an average age of about 50 years were studied. BDNF level among the glaucoma patients was higher (2.578 ± 1.394) than that of the controls (1.745 ± 0.707) (t = 3.436, P = 0.001). Glaucoma patients who were blind had the lowest levels of circulating BDNF (P = 0.022); the level of BDNF in the naïve patients (not yet placed on medication) is about five times less than in those patients placed on medication (P = 0.001). Circulating BDNF was associated with glaucoma treatment among the patients. Conclusion: The level of circulating BDNF in primary open angle glaucoma patients on treatment is high than those who were not on treatment. It influenced by coexisting medical conditions.
topic brain-derived neurotrophic factor
glaucoma
oculo-visual symptoms
url http://www.smjonline.org/article.asp?issn=1118-8561;year=2019;volume=22;issue=4;spage=164;epage=170;aulast=Saidu
work_keys_str_mv AT ahmedsaidu circulatingbrainderivedneurotrophicfactorlevelinpatientswithprimaryopenangleglaucoma
AT sadiqhassan circulatingbrainderivedneurotrophicfactorlevelinpatientswithprimaryopenangleglaucoma
AT ahmadushehumohammed circulatingbrainderivedneurotrophicfactorlevelinpatientswithprimaryopenangleglaucoma
AT isyakuumaryarube circulatingbrainderivedneurotrophicfactorlevelinpatientswithprimaryopenangleglaucoma
_version_ 1724896540171960320